Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Cash from Investing Activities

Rigel Pharmaceuticals Cash from Investing Activities Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Cash from Investing Activities from 2010 to 2020.
  • Rigel Pharmaceuticals Cash from Investing Activities for the quarter ending June 06, 2020 was $-5m a 94.38% decrease of -5m year over year
  • Rigel Pharmaceuticals Cash from Investing Activities for the last 12 months ending June 06, 2020 was $11m a 223.24% increase of 25m year over year
  • Rigel Pharmaceuticals Annual Cash from Investing Activities for 2019 was $-24m a 205.53% decrease of -49m from 2018
  • Rigel Pharmaceuticals Annual Cash from Investing Activities for 2018 was $25m a 178.00% increase of 44m from 2017
  • Rigel Pharmaceuticals Annual Cash from Investing Activities for 2017 was $-19m a 227.77% decrease of -44m from 2016
Other Cash Flow Metrics:
  • Rigel Pharmaceuticals Cash Flow from Operations for the quarter ending December 12, 2018 was $12m a 300.91% increase of 35m year over year
  • Rigel Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $1m a 1,495.75% increase of 15m year over year
  • Rigel Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $5m a 26.33% increase of 1m year over year
View Chart On Koyfin

Quarterly RIGL Cash from Investing Activities Data

06/2020$-5m
03/2020$24m
12/2019$-8m
09/2019$0m
06/2019$-15m
03/2019$-1m
12/2018$2m
09/2018$16m
06/2018$-16m
03/2018$23m

Annual RIGL Cash from Investing Activities Data

2019$-24m
2018$25m
2017$-19m
2016$25m
2015$45m
2014$63m
2013$72m
2012$-39m
2011$-63m
2010$-53m